Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Novel approaches and future strategies in management of upper GI tumours

Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA

Novel approaches and future strategies in management of upper GI tumours ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )

Advanced gastric cancer: What do we know and what we must know?

Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA

Advanced gastric cancer: What do we know and what we must know? ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )

Quality of life and local treatment of oligometastatic prostate cancer

Prof Claude Abbou - Clinique de l'Alma, Paris, France

Quality of life and local treatment of oligometastatic prostate cancer ( Prof Claude Abbou - Clinique de l'Alma, Paris, France )

Challenges in the treatment of upper urinary tract tumours

Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK

Challenges in the treatment of upper urinary tract tumours ( Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK )

Fostering resilience in young patients with cancer

Prof Joan Haase - Indiana University School of Nursing, Indianapolis, USA

Fostering resilience in young patients with cancer ( Prof Joan Haase - Indiana University School of Nursing, Indianapolis, USA )

Treating ovarian cancer patients with PARP inhibitors

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA

Treating ovarian cancer patients with PARP inhibitors ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )

PARP inhibitors and their side effects in solid tumour therapy

Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA

PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )

Benefits and challenges of using PARP inhibitors to treat metastatic breast...

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA

Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )

Cancer immunotherapy for the advanced practice nurse

Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA

Cancer immunotherapy for the advanced practice nurse ( Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA )

A clinical nurse specialist led multidisciplinary approach to breast cancer...

Colleen Zombek - Ohiohealth, Columbus, USA

A clinical nurse specialist led multidisciplinary approach to breast cancer survivorship ( Colleen Zombek - Ohiohealth, Columbus, USA )

How genetic testing is guiding the use of PARP inhibitors

Suzanne Mahon - Saint Louis University, Missouri, USA

How genetic testing is guiding the use of PARP inhibitors ( Suzanne Mahon - Saint Louis University, Missouri, USA )

More from ecancer